Despite representing only 4% of the world’s population, the United States accounts for over half of science Nobel Prizes ...

The president of the European Union’s executive branch, Ursula von der Leyen, faces a no-confidence vote this week linked in ...

J&J is looking to add a hormone-sensitive indication to its prostate cancer therapy, which was originally approved in 2023.

The Cyprus issue, water scarcity issues and forest fires in the EU and developments in the Middle east will be among the topics discussed in the European Parliament’s (EP) plenary session held in ...

Gabriella Ngang, of Farmington Hills, is one of three in Michigan to take part in a clinical trial of a new sickle cell ...

The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...

Wall Street's smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all ...

Robert "Bob" Cooper of the L.A. firm Gibson Dunn defended some of the country’s largest and most recognizable companies from ...

Vaccines have been rigorously tested, reviewed, and monitored for decades. They are one of the greatest success stories in ...

I didn’t set out to build a global innovation network spanning 45 countries. Here are four lessons from my journey.

In spite of its sustainable moat, Palantir Technologies is butting heads with historical headwinds that have a flawless track ...

Pfizer Inc. (NYSE: PFE) ranks among the best set-it-and-forget-it stocks to buy. On June 26, Pfizer Inc. (NYSE:PFE) declared ...